GEN Exclusives

More »

GEN Contributor

G. Steven Burrill

G. Steven Burrill is CEO of Burrill & Company, a San Francisco-based life science merchant bank with over $500 million under management. In 2002, Burrill was recognized as a biotech investment visionary by Scientific American. He currently serves as chairman of the boards of Icoria, Pharmasset, and Pyxis Genomics and is a member of the boards of Catalyst Biosciences, DepoMed, Galapagos Genomics, Targacept, and Third Wave Technologies. Prior to founding Burrill & Company in 1994, he spent 28 years with Ernst & Young, directing and coordinating the firm's services to clients in the biotechnology/life sciences/high technology/manufacturing industries worldwide.

More GEN Content From This Contributor:

GEN Articles

More GEN Content From This Contributor:

GEN Podcasts

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Children and Antipsychotic Drugs

Do you think children and adolescents with behavioral problems are overmedicated?